Spectral AI, Inc. (MDAI) vs Myomo, Inc. (MYO)
Spectral AI, Inc. and Myomo, Inc. are both Medical Devices companies. Myomo, Inc. is the larger, with a market value of $64.6M against $53.1M — 1.2× the size. Myomo, Inc. grew revenue faster over the last twelve months: 6.14% against −44.1%. Myomo, Inc. has the higher net margin (−33.5% vs −65.5%) and the lower return on invested capital (−167.9% vs 0.00%). Across the 16 metrics below, Myomo, Inc. leads on 11 and Spectral AI, Inc. on 5.
Valuation
Profitability
| Metric | MDAI | MYO | Medical Devices median |
|---|---|---|---|
| Gross margin | 42.92% | 68.35% | 56.01% |
| Operating margin | (77.17%) | (27.05%) | (15.03%) |
| Net margin | (65.54%) | (33.53%) | (20.40%) |
| Free cash flow margin | (83.66%) | (21.01%) | (7.24%) |
| Return on equity | 95.15% | (123.76%) | (15.32%) |
| Return on assets | (56.92%) | (39.20%) | (19.72%) |
| Return on invested capital | 0.00% | (167.90%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack